Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 iPLEX (Mecasermin Rinfabate [rDNA origin]) Injection
Company:  Insmed Inc.
Application No.:  021884
Approval Date: 12/12/2005


Date created: January 202006

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.